NEW YORK, NY / ACCESSWIRE / October 5, 2022 / Levi & Korsinsky, LLP announces that class action lawsuits have been filed on behalf of the shareholders of the following public companies. Shareholders interested in serving as lead plaintiffs have until the listed time limits to file a motion with the court. See the links provided for more details on the cases. There are no costs or obligations for you.

CODX Shareholders Click Here: https://www.zlk.com/pslra-1/co-dx-lawsuit-loss-submission-form?prid=32428&wire=1
KSS shareholders click here: https://www.zlk.com/pslra-1/kohls-class-action-loss-submission-form?prid=32428&wire=1
FLGT shareholders click here: https://www.zlk.com/pslra-1/fulgent-genetics-lawsuit-loss-submission-form?prid=32428&wire=1

* ADDITIONAL INFORMATION BELOW *

Co-Diagnostics, Inc. (NASDAQ:CODX)

This lawsuit is on behalf of a group of all individuals and entities that purchased the publicly traded securities of Co-Dx during the period May 12, 2022 through the market close on August 11, 2022 (4:00 p.m. ET).
Deadline for Lead Plaintiff : October 17, 2022
TO LEARN MORE VISIT: https://www.zlk.com/pslra-1/co-dx-lawsuit-loss-submission-form?prid=32428&wire=1

According to the lawsuit filed, (i) demand for the Company’s Logix Smart™ COVID-19 test had declined sharply during the quarter ended June 30, 2022 and (ii) as a result, defendants’ positive statements about demand for its Logix Smart ™ COVID-19 test lacked a sound basis.

Kohl’s Corporation (NYSE:KSS)

KSS lawsuit on behalf of: Investors who bought from October 20, 2020 to May 19, 2022
Deadline for Lead Plaintiff : November 1, 2022
TO LEARN MORE VISIT: https://www.zlk.com/pslra-1/kohls-class-action-loss-submission-form?prid=32428&wire=1

According to the Complaint, during the Class Period, Kohl’s Corporation made materially false and/or misleading statements and/or failed to disclose: (i) Kohl’s new strategic framework to “drive revenue growth”, “expand operating margin,”…